静脉注射硫酸可降低震的严重程度:一个案例系列
Alternative therapies in health and medicine
|June 9, 2023
概括
静脉注射硫酸对控制震有前途,为患者提供暂时的缓解和改善日常功能. 建议进行进一步的研究以量化其影响.
科学领域:
- 神经学 神经学
- 综合医学是一个整体的医学.
背景情况:
- ,通常与帕金森病 (PD) 相关,通常是用多巴胺激动剂来管理的,这些药物长期有效性有限.
- 预计PD的患病率将翻一番,需要低成本的补充和整合性健康干预措施.
- 硫酸因其在治疗震方面的潜在治疗益处而受到研究.
研究的目的:
- 为了研究静脉注射 (IV) 硫酸在治疗震方面的疗效.
- 介绍从接受IV硫酸治疗的四名患者的病例系列中得出的发现.
主要方法:
- 四名震患者在国家自然医学大学诊所接受了IV硫酸治疗.
- 治疗包括2000毫克的初始剂量,在安全检查 (ATHUMB缩写) 后,增加至3500毫克.
主要成果:
- 所有患者在IV硫酸治疗期间和之后都经历了震严重程度的降低.
- 患者报告24-48小时的缓解窗口和改善的日常生活活动.
- 四分之三的患者注意到延长缓解5-7天.
结论:
- 静脉注射硫酸在减少震严重程度方面表现出有效性.
- 未来的研究应该利用客观和自我报告的措施来量化IV硫酸对震的影响和持续时间.
更多相关视频
相关概念视频
Classification of Skeletal Muscle Relaxants
2.5K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
2.5K
Skeletal Muscle Relaxants: Adverse Effects
404
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
404
Mania and Antimanic Drugs: Overview
258
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
258
Skeletal Muscle Relaxants: Therapeutic Uses
523
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
523
Spasmolytic Agents: Chemical Classification
951
Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
951
Parkinson's Disease: Treatment
305
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
305


